Imperva (IMPV) Earns Buy Rating from Analysts at DA Davidson

DA Davidson initiated coverage on shares of Imperva (NASDAQ:IMPV) in a research report released on Tuesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $56.00 price objective on the software maker’s stock. DA Davidson also issued estimates for Imperva’s Q1 2019 earnings at $0.02 EPS, Q2 2019 earnings at $0.10 EPS, Q3 2019 earnings at $0.19 EPS and Q4 2019 earnings at $0.32 EPS.

Other equities analysts also recently issued reports about the stock. ValuEngine raised shares of Imperva from a sell rating to a hold rating in a report on Thursday, February 15th. Piper Jaffray raised shares of Imperva from a neutral rating to an overweight rating and set a $52.00 price objective on the stock in a report on Friday, February 9th. JPMorgan Chase downgraded shares of Imperva from a neutral rating to an underweight rating and set a $45.00 price objective on the stock. in a report on Tuesday, December 12th. Morgan Stanley increased their price objective on shares of Imperva from $37.00 to $39.00 and gave the company an underweight rating in a report on Friday, February 9th. Finally, Imperial Capital increased their price objective on shares of Imperva from $50.00 to $55.00 and gave the company an outperform rating in a report on Friday, February 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company. The company presently has an average rating of Hold and an average target price of $53.21.

IMPV opened at $46.35 on Tuesday. Imperva has a 52-week low of $37.17 and a 52-week high of $52.40.



Imperva (NASDAQ:IMPV) last posted its quarterly earnings data on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.27 by $0.13. The business had revenue of $91.10 million for the quarter, compared to the consensus estimate of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The company’s revenue was up 16.2% compared to the same quarter last year. During the same period last year, the firm posted $0.32 earnings per share. equities research analysts forecast that Imperva will post -0.17 earnings per share for the current year.

In related news, Director Anthony J. Bettencourt sold 66,037 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the completion of the sale, the director now directly owns 66,037 shares in the company, valued at $3,102,418.26. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CRO Michael D. Mooney sold 24,454 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the sale, the executive now owns 24,454 shares of the company’s stock, valued at $1,153,739.72. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in IMPV. SG Americas Securities LLC acquired a new stake in Imperva during the third quarter worth about $134,000. Quadrature Capital Ltd acquired a new stake in Imperva during the fourth quarter worth about $224,000. Koch Industries Inc. acquired a new stake in Imperva during the fourth quarter worth about $229,000. Principal Financial Group Inc. increased its position in Imperva by 51.7% during the third quarter. Principal Financial Group Inc. now owns 7,067 shares of the software maker’s stock worth $307,000 after purchasing an additional 2,409 shares during the last quarter. Finally, Renaissance Group LLC acquired a new stake in Imperva during the fourth quarter worth about $341,000.

ILLEGAL ACTIVITY WARNING: This report was first posted by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at https://dakotafinancialnews.com/2018/04/13/imperva-impv-earns-buy-rating-from-analysts-at-da-davidson.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply